MIGAL Accelerates COVID-19 Vaccine Development
Source: Dassault Systèmes Americas
When COVID-19 became a pandemic, scientists at the Migal Galilee Research Institute in Israel – an academic research and development center – began using applications and computational tools to apply its research to the study of COVID-19 mutations. Watch the video to learn how they used these tools to accelerate their research and development of a possible vaccine against SARS-CoV-2.
VIEW THE VIDEO!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online
X
Subscribe to Drug Discovery Online
Dassault Systèmes Americas
This website uses cookies to ensure you get the best experience on our website. Learn more